BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 23402464)

  • 1. The evolution of oral anticoagulant therapy.
    Dittus C; Ansell J
    Prim Care; 2013 Mar; 40(1):109-34. PubMed ID: 23402464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct inhibitors of coagulation proteins - the end of the heparin and low-molecular-weight heparin era for anticoagulant therapy?
    Laux V; Perzborn E; Heitmeier S; von Degenfeld G; Dittrich-Wengenroth E; Buchmüller A; Gerdes C; Misselwitz F
    Thromb Haemost; 2009 Nov; 102(5):892-9. PubMed ID: 19888525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Rivaroxaban: mode of action].
    Drouet L
    Ann Fr Anesth Reanim; 2008 Dec; 27 Suppl 3():S9-15. PubMed ID: 19185786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Old versus new oral anticoagulants: focus on pharmacology.
    Fareed J; Thethi I; Hoppensteadt D
    Annu Rev Pharmacol Toxicol; 2012; 52():79-99. PubMed ID: 21819239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticoagulant therapy: basic principles, classic approaches and recent developments.
    Sinauridze EI; Panteleev MA; Ataullakhanov FI
    Blood Coagul Fibrinolysis; 2012 Sep; 23(6):482-93. PubMed ID: 22732252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changing trends in anti-coagulant therapies. Are heparins and oral anti-coagulants challenged?
    Fareed J; Iqbal O; Cunanan J; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
    Int Angiol; 2008 Jun; 27(3):176-92. PubMed ID: 18506123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The new oral anticoagulants, do they change the benefit vs. risk for thromboprophylaxis in association to ambulatory surgery?
    Squizzato A; Romualdi E; Dentali F; Ageno W
    Curr Opin Anaesthesiol; 2010 Dec; 23(6):722-5. PubMed ID: 20847691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in anticoagulation: focus on dabigatran, an oral direct thrombin inhibitor.
    Augoustides JG
    J Cardiothorac Vasc Anesth; 2011 Dec; 25(6):1208-12. PubMed ID: 21982327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival of heparins, oral anticoagulants, and aspirin after the year 2010.
    Fareed J; Hoppensteadt DA; Fareed D; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
    Semin Thromb Hemost; 2008 Feb; 34(1):58-73. PubMed ID: 18393143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral anticoagulation with factor Xa and thrombin inhibitors: on the threshold of change.
    Zikria JC; Ansell J
    Curr Opin Hematol; 2009 Sep; 16(5):347-56. PubMed ID: 19550318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in anticoagulation therapy: the role of selective inhibitors of factor Xa and thrombin in thromboprophylaxis after major orthopedic surgery.
    Andersen JC
    Semin Thromb Hemost; 2004 Dec; 30(6):609-18. PubMed ID: 15630666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel anticoagulants and the future of anticoagulation.
    Garcia D
    Thromb Res; 2009; 123 Suppl 4():S50-5. PubMed ID: 19303505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unanswered questions in venous thromboembolism.
    Weitz JI
    Thromb Res; 2009; 123 Suppl 4():S2-S10. PubMed ID: 19303498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laboratory monitoring of anticoagulation: where do we stand?
    Tripodi A; van den Besselaar A
    Semin Thromb Hemost; 2009 Feb; 35(1):34-41. PubMed ID: 19308891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The challenge of regulating anticoagulant drugs: focus on warfarin.
    Mann KG
    Am Heart J; 2005 Jan; 149(1 Suppl):S36-42. PubMed ID: 15644792
    [No Abstract]   [Full Text] [Related]  

  • 16. Current challenges and future prospects in oral anticoagulant therapy.
    Czuprynska J; Patel JP; Arya R
    Br J Haematol; 2017 Sep; 178(6):838-851. PubMed ID: 28573648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral anticoagulant initiation: rationale for the use of warfarin dosing nomograms.
    Crowther MA
    Semin Vasc Med; 2003 Aug; 3(3):255-60. PubMed ID: 15199458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A preliminary assessment of the critical differences between novel oral anticoagulants currently in development.
    McBride BF
    J Clin Pharmacol; 2005 Sep; 45(9):1004-17. PubMed ID: 16100294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging anticoagulants for the treatment of venous thromboembolism.
    Weitz JI
    Thromb Haemost; 2006 Sep; 96(3):274-84. PubMed ID: 16953267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New oral anticoagulants in atrial fibrillation.
    Turpie AG
    Eur Heart J; 2008 Jan; 29(2):155-65. PubMed ID: 18096568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.